We are live on ! Find out more
FCMV

Foresite Capital Management VI Portfolio holdings

AUM $460M
1-Year Est. Return 261.77%
This Fund
S&P 500
This Quarter Est. Return
-19.51%
1 Year Est. Return
+261.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$224M
AUM Growth
–
Cap. Flow
+$265M
Cap. Flow %
118.29%
Top 10 Hldgs %
92.41%
Holding
14
New
14
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$76M
2
ALMS
Alumis Inc
ALMS
+$42.1M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$20.8M
4
RAPT
RAPT Therapeutics
RAPT
+$19.8M
5
BCAX
Bicara Therapeutics
BCAX
+$19.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$6.38B
$63.7M 28.39%
+2,221,474
New +$76M
ALMS
2
Alumis Inc
ALMS
$3.44B
$33M 14.72%
+4,202,670
New +$42.1M
CNTA
3
DELISTED
Centessa Pharmaceuticals
CNTA
$21M 9.35%
+1,253,379
New +$20.8M
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$19.8M 8.8%
+1,562,500
New +$19.8M
BCAX
5
Bicara Therapeutics
BCAX
$1.78B
$16.5M 7.37%
+950,000
New +$19.8M
EWTX icon
6
Edgewise Therapeutics
EWTX
$4.39B
$15.6M 6.96%
+585,000
New +$18.6M
GPCR icon
7
Structure Therapeutics
GPCR
$3.4B
$11.4M 5.08%
+420,000
New +$14.9M
AKRO
8
DELISTED
Akero Therapeutics
AKRO
$10.2M 4.52%
+365,000
New +$11.1M
CRVS icon
9
Corvus Pharmaceuticals
CRVS
$1.1B
$8.46M 3.77%
+1,581,233
New +$11.8M
CGEM icon
10
Cullinan Oncology
CGEM
$1.07B
$7.73M 3.44%
+634,558
New +$9.12M
ALLO icon
11
Allogene Therapeutics
ALLO
$563M
$7.34M 3.27%
+3,448,275
New +$8.5M
KYMR icon
12
Kymera Therapeutics
KYMR
$8.82B
$5.89M 2.62%
+146,332
New +$6.61M
CASI
13
DELISTED
CASI Pharmaceuticals
CASI
$3.76M 1.68%
+1,329,383
New +$6.31M
VRDN icon
14
Viridian Therapeutics
VRDN
$2.15B
$37.8K 0.02%
+1,974
New +$42.9K

Similar funds

MCB
Morton Community Bank East Peoria, Illinois $460M AUM 17.72% 1-Year Est. Return
WCM
Weaver Capital Management Suwanee, Georgia $461M AUM 20.77% 1-Year Est. Return
PC
Pureheart Capital Singapore $459M AUM 23.59% 1-Year Est. Return
PIN
Prudent Investors Network Lake Forest, California $459M AUM 9.48% 1-Year Est. Return
FCG
Fielder Capital Group Nashville, Tennessee $459M AUM 48.94% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return

Foresite Capital Management VI's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for Foresite Capital Management VI, which disclosed 14 positions worth $224M. Its ten largest holdings account for 92% of the portfolio.

Its largest position is CG Oncology: 2,221,474 shares worth $63.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Foresite Capital Management VI's largest Q4 2024 buy was CG Oncology: 2,221,474 shares worth $63.7M.
  • Foresite Capital Management VI's ten largest holdings make up 92% of its $224M portfolio in Q4 2024.
  • Foresite Capital Management VI disclosed 14 positions in Q4 2024, its first 13F filing on record.

Based on Foresite Capital Management VI's 13F filing for Q4 2024, filed 14 Feb 2025.